Cryoablation catheters

Freezor™ cardiac cryoablation catheter

<p>The Freezor™ cardiac cryoablation catheters are single-use catheters designed to ablate cardiac tissue by creating focal lesions.</p>

Ordering information

Contact a representative

Indications, Safety, and Warnings

Freezor™ MAX cardiac cryoablation catheter

Freezor™ Xtra cardiac cryoablation catheter

Freezor™ cardiac cryoablation catheterIndicationsThe Freezor™ cardiac cryoablation catheter, CryoConsole™ system, and related accessories are indicated for the cryoablation of the conducting tissues of the heart in the treatment of adult and pediatric patients over two years of age, with atrioventricular nodal reentrant tachycardia (AVNRT).
ContraindicationsThis device is contraindicated in patients with active systemic infection, cryoglobulinemia, intracardiac mural thrombus, myxoma, interatrial baffle or patch.
Warnings/PrecautionsClosely monitor AV conduction during cryo energy delivery near the AV node due to possible risk of complete atrioventricular (AV) block. Immediately terminate energy delivery if partial or complete AV block is noted. Cryoablation involving coronary vessels has been associated with subsequent clinically significant arterial stenosis. Care should be taken to minimize unnecessary contact with coronary vessels during cryoablation. Endotoxins may cause pyrogenic responses in patients including inflammation and fever which can result in anaphylactic shock and death. Caution should be used with regard to endotoxins in pediatric populations as standard endotoxin limits do not differentiate between adult and pediatric populations. Ethylene oxide residuals remaining after sterilization are known to cause a potential increase in a number of biological effects including irritation, organ damage, mutagenicity and carcinogenicity. Calculations for ethylene oxide and ethylene chlorohydrin residuals indicate that the risk of these effects may be increased in patients under 3.8 kg. Avoid catheter entanglement with other catheters devices or wires. Closely monitor patients undergoing cardiac ablation procedures during the post-ablation period for clinical adverse events. Do not re-use, reprocess, or resterilize this device for purpose of reuse. This device is intended only to be used once for a single patient. The use of CryoMapping mode does not prevent injuries to the patient. CryoMapping mode is used to determine if the site is appropriate for ablation. The Freezor™ catheter contains a pressurized refrigerant during operation. Release of this gas into the circulatory system due to equipment failure or misuse could result in gas embolism. Do not pull on the catheter, sheath, umbilical cables, or console while the catheter tip is frozen to the tissue, as this may lead to tissue injury. Always advance and withdraw components slowly to minimize the vacuum created and therefore minimize the risk of air embolism. Do not connect the Freezor™ catheter to any radiofrequency (RF) generator or use the Freezor™ catheter to deliver RF ablation energy. Before powering up an RF generator of applying RF energy, disconnect the cryoablation catheter from the CryoConsole™ system. The use of fluoroscopy during catheter ablation procedures presents the potential for significant X-ray exposure to both patients and laboratory staff. Give careful consideration before using the device in pregnant women. Avoid positioning the catheter around the chordae tendineae, as this increases the likelihood of catheter entrapment within the heart. Do not pass the catheter through a prosthetic heart valve (mechanical or tissue).Catheter handling:

Use extreme care when manipulating the catheter. Lack of careful attention can result in injury such as perforation or tamponade.

Do not use excessive force to advance, withdraw, the catheter, especially if resistance is encountered.

Do not use the catheter if it is kinked, damaged, or cannot be straightened.

Straighten the cooling segment before inserting or withdrawing the catheter.

Do not at any time preshape or bend the catheter shaft or cooling segment.

Catheter advancement should be performed under fluoroscopic guidance or other appropriate visualization technique.

Use only isolated equipment (IEC 60601-1 Type CF equipment, or equivalent) with the CryoConsole™ system and catheters. The Medtronic cryoablation catheters, refrigerant tanks, and other Medtronic CryoConsole™ components should only be used with the Medtronic CryoConsole™ system. If the sterile packaging or catheter is damaged, do not use the catheter. This equipment should be used only by physicians that perform cardiac ablation. Do not expose the catheter handle or coaxial and electrical connectors to fluids or solvents. Disconnect the catheter’s electrical connection prior to cardioversion/defibrillation. Administer appropriate levels of peri-procedural anticoagulation therapy for patients undergoing right-sided procedures. The Freezor™ catheter has not been evaluated for safety and compatibility in the magnetic resonance (MR) environment. Scanning a patient during the use of this device may result in patient injury.Potential ComplicationsPotential complications that may be associated with cardiac catheterization and ablation listed alphabetically below include, but are not limited to: Access site complications including, hematoma, infection, thrombosis, ecchymosis, AV fistula, bleeding from puncture site, hemorrhage; arrhythmias (such as atrial fibrillation, atrial flutter, tachycardia); cardiac arrest and/or death; chest discomfort, pain or pressure; coronary artery spasm/stenosis; damage to heart tissue or vasculature; endocarditis; entrapment; heart block, requiring permanent pacemaker; hemothorax; infection; perforation of venous, cardiac or surrounding tissue, pericardial effusion, tamponade; pericarditis; phrenic nerve injury; pleural effusion; pneumothorax; pseudoaneurysm; pulmonary edema; pulmonary embolism; stroke; tissue infarction (such as myocardial infarction or renal infarction); thrombus; transient ischemic attack; vagal nerve injury (such as gastroparesis); vasovagal reaction.Refer to the device technical manual for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 800-238-2518 and/or consult the Medtronic website at www.medtronic.com.Caution: Federal law (United States) restricts these devices to sale by or on the order of a physician.Back to topFreezor™ MAX cardiac cryoablation catheterIndicationsThe Freezor™ MAX cardiac cryoablation catheter is used as an adjunctive device in the endocardial treatment of paroxysmal and persistent atrial fibrillation (episode duration less than six months) in conjunction with the Arctic Front™ family of cardiac cryoablation catheters for the following uses: 1) Gap cryoablation to complete electrical isolation of the pulmonary veins 2) Cryoablation of focal trigger sites and 3) Creation of ablation line between the inferior vena cava and the tricuspid valve.ContraindicationsUse of Freezor™ MAX cardiac cryoablation catheter is contraindicated in patients with active systemic infections, in patients with cryoglobulinemia, intracardiac mural thrombus, myxoma or interatrial baffle or patch. The Freezor™ MAX cardiac cryoablation catheter is also contraindicated in patients with a body mass under 4.4 kg.Warnings/PrecautionsDo not reuse or reprocess this device for purpose of reuse. This catheter is intended only to be used once for a single patient. Do not connect the cryoablation catheter to a radiofrequency (RF) generator or use it to deliver RF energy. Disconnect the catheter’s electrical connection prior to cardioversion/defibrillation.Catheter handling:

Use extreme care when manipulating the catheter. Lack of careful attention can result in injury such as perforation or tamponade.

Do not use excessive force to advance, withdraw the catheter, especially if resistance is encountered.

Do not use the catheter if it is kinked, damaged, or cannot be straightened. Straighten the cooling segment before inserting or withdrawing the catheter.

Do not at any time preshape or bend the catheter shaft or cooling segment.

Catheter advancement should be performed under fluoroscopic guidance or other appropriate visualization technique.

Avoid positioning the catheter around the chordae tendineae. The catheter contains pressurized refrigerant during operation. Release of this gas into the circulatory system due to equipment failure or misuse could result in gas embolism. Do not pass the catheter through a prosthetic heart valve (mechanical or tissue). Use adequate fluoroscopic visualization or other appropriate visualization technique during a transaortic approach to avoid placing the ablation catheter within the coronary vasculature. Do not pull on the catheter, sheath, umbilical cables, or console while the catheter is frozen to the tissue, as this may lead to tissue injury. Always advance and withdraw components slowly to minimize the vacuum created. Closely monitor AV conduction during cryo energy delivery near the AV node due to possible risk of complete atrioventricular block.Perform cryoablation procedures only within the environmental parameters. Do not expose the catheter handle or coaxial and electrical connectors to fluids or solvents. The use of fluoroscopy during catheter ablation procedures presents the potential for significant X-ray exposure to both patients and laboratory staff. Give careful consideration before using the catheter in pregnant women. Use only isolated equipment (IEC 60601-1 Type CF equipment, or equivalent) with the CryoConsole™ system and catheters. The safety of the catheter in the MR environment is unknown (such as any heating, migration, or image artifacts). Scanning a patient during the use of this device may result in patient injury. Avoid catheter entanglement with other catheters, devices, or wires. Closely monitor patients undergoing cardiac ablation procedures during the post-ablation period for clinical adverse events. Before powering up an RF generator or applying RF energy, disconnect the cryoablation catheter from the CryoConsole™ system. If the device is damaged or the integrity of the sterilization barrier has been compromised, do not use the product. The Medtronic cryoablation catheters, refrigerant tanks, and other Medtronic CryoConsole™ components should only be used with the Medtronic CryoConsole™ system.The Freezor™ MAX catheter was not studied for safety of changes in anticoagulation therapy in patients with paroxysmal atrial fibrillation. This equipment should be used only by physicians that perform cryoablation procedures. Cryoablation procedures should be performed only in a fully equipped facility.Potential ComplicationsPotential complications/adverse events from cardiac catheterization and ablation include, but are not limited to the following: Access site complications including, hematoma, infection, thrombosis, ecchymosis, AV fistula, bleeding from the puncture site, hemorrhage; arrhythmias (such as atrial fibrillation, atrial flutter, tachycardia); cardiac arrest; chest discomfort, pain or pressure; coronary artery spasm/stenosis; damage to heart tissue or vasculature; death; endocarditis; entrapment; esophageal damage (such as atrio-esophageal fistula); heart block, potentially requiring implantation of a permanent pacemaker; hemothorax; infection; perforation of venous, cardiac or surrounding tissue, pericardial effusion, tamponade; pericarditis; phrenic nerve injury; pleural effusion; pneumothorax; pseudoaneurysm; pulmonary edema; pulmonary embolism; stroke; tissue infarction (such as myocardial infarction or renal infarction); thrombus; transient ischemic attack; vagal nerve injury (such as gastroparesis); vasovagal reaction.Refer to the device technical manual for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 800-328-2518 and/or consult the Medtronic website at www.medtronic.com.Caution: Federal Law (United States) restricts this device to sale by or on the order of a physician.Back to topFreezor™ Xtra cardiac cryoablation catheterIndicationsThe Freezor™ Xtra cardiac cryoablation catheter, CryoConsole™ system, and related accessories are indicated for the cryoablation of the conducting tissues of the heart in the treatment of adult and pediatric patients over two years of age with atrioventricular nodal reentrant tachycardia (AVNRT). The Freezor™ Xtra catheter is also intended for minimally invasive cardiac surgery procedures, including surgical treatment of cardiac arrhythmias. The Freezor™ Xtra catheter freezes the target tissue and blocks the electrical conduction by creating an inflammatory response or cryonecrosis.ContraindicationsThe Freezor™ Xtra cardiac cryoablation catheter is contraindicated in patients with the following conditions:

Active systemic infections

Cryoglobulinemia

Intracardiac mural thrombus

Myxoma

Interatrial baffle or patch

Warnings/PrecautionsDo not reuse, reprocess, or resterilize this catheter for purpose of reuse. This catheter is intended only to be used once for a single patient. Closely monitor AV conduction during cryo energy delivery near the AV node due to possible risk of complete atrioventricular (AV) block. Immediately terminate energy delivery if partial or complete AV block is noted. The use of CryoMapping mode does not prevent injuries to the patient. CryoMapping mode is used to determine if the site is appropriate for ablation. The catheter contains pressurized refrigerant during operation. Release of this gas into the body or circulatory system due to equipment failure or misuse could result in gas embolism, pericardial tamponade, tissue emphysema, or other patient injury. Always advance and withdraw components slowly to minimize the vacuum created and therefore minimize the risk of air embolism. Endotoxins may cause pyrogenic responses in patients including inflammation and fever which can result in anaphylactic shock and death. Caution should be used with regard to endotoxins in pediatric populations as standard endotoxin limits do not differentiate between adult and pediatric populations. Ethylene oxide residuals remaining after sterilization are known to cause a potential increase in a number of biological effects including irritation, organ damage, mutagenicity, and carcinogenicity. Calculations for ethylene oxide and ethylene chlorohydrin residuals indicate that the risk of these effects may be increased in patients under 3.8kg. Avoid catheter entanglement with other catheters, devices, or wires. Closely monitor patients undergoing cardiac ablation procedures during the post-ablation period for clinical adverse events. Do not pull on the Freezor™ Xtra catheter, sheath, umbilical cables, or console while the catheter is frozen to the tissue, as this may lead to tissue injury. Do not connect the Freezor™ Xtra catheter to a radiofrequency (RF) generator or use it to deliver RF ablation energy. Before powering up an RF generator or applying RF energy, disconnect the cryoablation catheter from the CryoConsole™ system. The use of fluoroscopy during ablation procedures presents the potential for significant X-ray exposure to both patients and laboratory staff. Give careful consideration before using the device in pregnant women.Catheter handling:

Use extreme care when manipulating the catheter. Lack of careful attention can result in injury such as perforation or tamponade.

Do not use excessive force to advance or withdraw the catheter, especially if resistance is encountered.

Do not use the catheter if it is kinked, damaged, or cannot be straightened.

Straighten the cooling segment before inserting or withdrawing the catheter.

Do not at any time preshape or bend the catheter shaft or cooling segment.

Catheter advancement should be performed under fluoroscopic guidance or other appropriate visualization technique.

Use only isolated equipment (IEC 60601-1 Type CF equipment, or equivalent) with the CryoConsole™ system and catheters. The Freezor™ Xtra catheter has not been evaluated for safety and compatibility in the magnetic resonance (MR) environment. Scanning a patient during the use of this device may result in patient injury. The Medtronic cryoablation catheters, refrigerant tanks, and other Medtronic CryoConsole™ components should only be used with the Medtronic CryoConsole™ system. If the sterile packaging or catheter is damaged, do not use the catheter. Do not expose the catheter handle or coaxial and electrical connectors to fluids or solvents. Disconnect the catheter’s electrical connection prior to cardioversion/defibrillation. Cryoablation involving coronary vessels with liquid nitrous oxide systems has been associated with subsequent clinically significant arterial stenosis. Care should be taken to minimize unnecessary contact with coronary vessels during cryoablation.Avoid positioning the catheter around the chordae tendineae, as this increases the likelihood of catheter entrapment within the heart. Do not pass the catheter through a prosthetic heart valve (mechanical or tissue). Administer appropriate levels of peri-procedural anticoagulation therapy for patients undergoing endocardial right-sided procedures. This equipment should be used only by physicians that perform cardiac ablation.Potential ComplicationsPotential complications that may be associated with cardiac catheterization and ablation listed alphabetically below include, but are not limited to: Access site complications including, hematoma, infection, thrombosis, ecchymosis, AV fistula, bleeding from puncture site, hemorrhage; arrhythmias (such as atrial fibrillation, atrial flutter, tachycardia); cardiac arrest and/or death; chest discomfort, pain or pressure; coronary artery spasm/stenosis; damage to heart tissue or vasculature; endocarditis; entrapment; heart block, requiring permanent pacemaker; hemothorax; infection; perforation of venous, cardiac or surrounding tissue, pericardial effusion, tamponade; pericarditis; phrenic nerve injury; pleural effusion; pneumothorax; pseudoaneurysm; pulmonary edema; pulmonary embolism; stroke; tissue infarction (such as myocardial infarction or renal infarction); thrombus; transient ischemic attack; vagal nerve injury (such as gastroparesis); vasovagal reaction.Refer to the device technical manual for detailed information regarding the procedure, indications, contraindications, warnings, precautions, and potential complications/adverse events. For further information, please call Medtronic at 800-328-2518.Caution: Federal law (United States) restricts this device to sale by or on the order of a physician.Back to topMAJ_83945

Features

Freezor™ and Freezor Xtra™ catheters

Restoring life’s rhythm. Big and small.

Freezor™ and Freezor™ Xtra cardiac cryoablation catheters freeze the target tissue and block the electrical conduction by creating scar tissue. The catheters are designed to create focal lesions to treat (AVNRT) for both adult and pediatric^† patients.

The Freezor™ Xtra catheter is also intended for minimally invasive cardiac surgery procedures, including surgical treatment of cardiac arrhythmias.

Freezor™ catheter details

Tip length: 4 mm
2.5 mm
5 mm
2.5 mm
Shaft: 7 Fr, 108 cm

This image shows the Freezor™ cardiac cryoablation catheter specifications.

Freezor™ Xtra catheter details

Tip length: 6 mm 
2.5 mm 
5 mm 
2.5 mm 
Shaft: 7 Fr, 108 cm

This image shows the Freezor™ Xtra cardiac cryoablation catheter specifications.

Clinical evidence

Proven. Predictable.

Freezor™ catheters are the only FDA-approved ablation catheters for the treatment of AVNRT in both pediatric^† and adult patients. Patient outcomes include:

0% of reported AVNRT cases resulted in permanent AV block^1–16
89% quality of life improvement after cryoablation^1–16
≥ 95% acute procedural success from AVNRT^1–16

Download clinical evidence (open in new window)

Testimonial

The first of its kind

Hear from a pediatric electrophysiologist to learn more about the Freezor™ cardiac cryoablation catheters, the first and only FDA-approved devices for the treatment of both pediatric^† and adult AVNRT.

Freezor™ MAX

Look no further.

The Freezor™ MAX cardiac cryoablation catheter is an adjunctive device used in the endocardial treatment of paroxysmal and persistent atrial fibrillation (episode duration less than six months) to complete pulmonary vein isolation (PVI), if needed. It may also be used for: 

Gap cryoablation to complete electrical isolation of the pulmonary veins 
Cryoablation of focal trigger sites 
Creation of ablation line between the inferior vena cava and the tricuspid valve

Freezor™ MAX catheter details

Tip length: 8 mm 
3.5 mm 
5 mm 
2 mm 
Shaft: 9 Fr, 90 cm

This image shows the Freezor™ MAX cardiac cryoablation catheter specifications.

Ordering information

Freezor™ cardiac cryoablation catheter

Item Number	Description	Tip length (mm)	Electrode spacing (mm)	Catheter diameter (Fr)	Shaft length (cm)	Recommended introducer (Fr)	Reach (mm)
207F1	Short/red	4	2.5 – 5 – 2.5	7	108	8	47
207F3	Medium/blue	4	2.5 – 5 – 2.5	7	108	8	53
207F5	Long/orange	4	2.5 – 5 – 2.5	7	108	8	58

Freezor™ Xtra cardiac cryoablation catheter

Item Number	Description	Tip length (mm)	Electrode spacing (mm)	Catheter diameter (Fr)	Shaft length (cm)	Recommended introducer (Fr)	Reach (mm)
217F1	Short/red	6	2.5 – 5 – 2.5	7	108	8	49
217F3	Medium/blue	6	2.5 – 5 – 2.5	7	108	8	55
217F5	Long/orange	6	2.5 – 5 – 2.5	7	108	8	60

Freezor™ MAX cardiac cryoablation catheter

Item Number	Description	Tip length (mm)	Electrode spacing (mm)	Catheter diameter (Fr)	Shaft length (cm)	Recommended introducer (Fr)	Reach (mm)
209F3	Medium/blue	8	3.5 – 5 – 2.5	9	90	10	55
209F5	Long/orange	8	3.5 – 5 – 2.5	9	90	10	66

Freezor™ cardiac cryoablation catheter